Differential effects of diabetes and glomerulonephritis on glomerular basement membrane composition

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 1, 1996, Pages 69-77

  Brees, Douglas K ^a,d   Hutchison, Florence N ^a   Cole, Gregory J ^b   Williams Jr , James C ^c  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; ENTACTIN; FIBRONECTIN; LAMININ; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; DIABETIC NEPHROPATHY; GLOMERULUS BASEMENT MEMBRANE; MALE; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MICROALBUMINURIA; NONHUMAN; PATHOGENESIS; RAT; STREPTOZOCIN DIABETES;

EID: 0029939864     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-43993     Document Type: Article

References (42)

1. Williams JC Jr. Permeability of basement membranes to macromolecules. Proc Soc Exp Biol Med 207:13-19, 1994.
2. Paulsson M. Basement membrane proteins: Structure, assembly, and cellular interactions. CRC Crit Rev Biochem Mol Biol 27:93-127, 1992.
3. Weber M. Basement membrane proteins. Kidney Int 41:620-628, 1992.
4. Martin GR, Timpl R, Kuhn K. Basement membrane proteins: Molecular structure and function. Adv Prot Chem 39:1-50, 1988.
5. Border WA, Okuda S, Nakamura T. Extracellular matrix and glomerular disease. Semin Nephrol 9:307-317, 1989.
6. Steffes MW, Bilous RW, Sutherland DER, Mauer SM. Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684, 1992.
7. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993.
8. Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti GC, Osterby R. Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 41:741-748, 1992.
9. Olgemoller B, Schleicher E. Alterations of glomerular matrix proteins in the pathogenesis of diabetic nephropathy. Clin Invest 71:S13-S19, 1993.
10. Mathiesen ER. Prevention of diabetic nephropathy. Microalbuminuria and perspectives for intervention in insulin-dependent diabetes. Dan Med Bull 40:273-285, 1993.
11. Rossing P, Hommel E, Smidt UM, Parving H-H. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37:511-516, 1994.
12. Fogel MA, Boyd CD, Leardkamolkarn V, Abrahamson DR, Minto AWM, Salant DJ. Glomerular basement membrane expansion in Passive Heymann Nephritis: Absence of increased synthesis of type IV collagen, laminin, or fibronectin. Am J Pathol 138:465-475, 1991.
13. Floege J, Johnson RJ, Gordon K, Yoshimura A, Campbell C, Iruela-Arispe L, Alpers CE, Couser WB. Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy. Kidney Int 42:573-585, 1992.
14. Tamsma JT, Van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes HHPJ, Woude FJ. Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decreased heparan sulphate in the glomerular basement membrane. Diabetologia 37:313-320, 1994.
15. Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 58:135-139, 1972.
16. Brees DK, Ogle RC, Williams JC Jr. Laminin and fibronectin content of mouse glomerular and tubular basement membrane. Renal Physiol Biochem 18:1-11, 1995.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
19. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 104:205-214, 1980.
20. Buee L, Boyle NJ, Zhang L, Delacourte A, Fillit HM. Optimization of an alcian blue dot-blot assay for the detection of glycosaminoglycans and proteoglycans. Anal Biochem 195:238-242, 1991.
21. Hudson BG, Spiro RG. Studies on the native and reduced alkylated renal glomerular basement membrane. Solubility, subunit size, and reaction with cyanogen bromide. J Biol Chem 247:4229-4238, 1972.
22. Mohan PS, Spiro RG. Macromolecular organization of basement membranes. Characterization and comparison of glomerular basement membrane and lens capsule components by immunochemical and lectin affinity procedures. J Biol Chem 261(9):4328-4336, 1986.
23. Falk RJ, Scheinman JI, Mauer SM, Michael AF. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32:34-39, 1983.
24. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, Hassell JR. Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196-203, 1990.
25. Ihm C-G, Lee GSL, Nast CC, Artishevsky A, Guillermo R, Levin PS, Glassock RJ, Adler SG. Early increased renal procollagen α1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768-777, 1992.
26. Abrass CK, Peterson CV, Raugi GJ. Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 37:1695-1702, 1988.
27. Das A, Frank RN, Zhang NL. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat. Diabetologia 33:515-521, 1990.
28. Karttunen T, Risteli J, Autio-Harmainen H, Risteli L. Effect of age and diabetes on type IV collagen and laminin in human kidney cortex. Kidney Int 30:586-591, 1986.
29. Knecht R, Leber R, Hasslacher C. Degradation of glomerular basement membrane in diabetes. I. Susceptibility of diabetic and nondiabetic basement membrane to proteolytic degradation of isolated glomeruli. Res Exp Med 187:323-328, 1987.
30. Nerlich A, Schleicher E. Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899, 1991.
31. Shimomura H, Spiro RG. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes Decreased levels of heparan sulfate proteoglycan and laminin. Diabetes 36:374-381, 1987.
32. Ayo SH, Radnik RA, Glass WF II, Garoni JA, Rampt ER, Appling DR, Kreisberg JI. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991.
33. Katz A, Fish AJ, Kleppel MM, Hagen SG, Michael AF, Butkowski RJ. Renal entactin (nidogen): Isolation, characterization and tissue distribution. Kidney Int 40:643-652, 1991.
34. Kanwar YS, Linker A, Farquhar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86:688-693, 1980.
35. Van den Born J, Van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41:115-123, 1992.
36. Hunsicker LG, Bertolatus JA. Charged compounds of the glomerular filter and their role in normal and disordered permselectivity. Artific Organs 11:468-477, 1987.
37. Parthasarathy N, Spiro RG. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 31:738-741, 1982.
38. Kanwar YS, Rosenzweig LJ, Linker A, Jakubowski ML. Decreased de novo synthesis of glomerular proteoglycans in diabetes: Biochemical and autoradiographic evidence. Proc Natl Acad Sci USA 80:2272-2275, 1983.
39. Wu V, Wilson B, Cohen MP. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 36:679-683, 1987.
40. Makino H, Ikeda S, Haramoto T, Ota Z. Heparan sulfate proteoglycans are lost in patients with diabetic nephropathy. Nephron 61:415-421, 1992.
41. Nakamura Y, Myers BD. Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37:1202-1211, 1988.
42. Minto AW, Fogel MA, Natori Y, O'Meara YM, Abrahamson DA, Smith B, Salant DJ. Expression of type I collagen mRNA in glomeruli of rats with passive Heymann nephritis. Kidney Int 43:121-127, 1993.